Vaxart (NASDAQ: VXRT) reported Q4 EPS of ($0.33), $0.23 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $28.7 million versus the consensus estimate of $20.77 million.

For earnings history and earnings-related data on Vaxart (VXRT) click here.